PBM Study, Corniche Hospital, 2018-2025, Transfusion Reduction
Summary
ClinicalTrials.gov registry entry NCT07544017 describes an observational study conducted at Corniche Hospital assessing Patient Blood Management (PBM) implementation and blood product utilization among obstetric deliveries from 2018 to 2025. The primary objective is to estimate changes over time in mean blood product units transfused per delivery, with a hypothesis that increasing PBM maturity following comprehensive implementation in 2022 will correlate with significant reductions after adjusting for case-mix changes.
“Primary Objective To estimate the change over time in the mean number of blood product units transfused per delivery (combined and by product type).”
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 676 changes logged to date.
What changed
This ClinicalTrials.gov registry entry documents an observational study examining Patient Blood Management (PBM) practices in obstetrics at Corniche Hospital spanning 2018 to 2025. The study aims to measure whether comprehensive PBM implementation in 2022 reduced mean blood product units transfused per delivery after adjusting for case-mix changes. Healthcare institutions and public health authorities should note this study as a data source on PBM effectiveness in obstetric settings, though the registry entry itself imposes no compliance obligations.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Patient Blood Management in Obstetrics
Observational NCT07544017 Kind: OBSERVATIONAL Apr 22, 2026
Abstract
Obstetric anemia and hemorrhage are major causes of maternal morbidity and increased healthcare utilization. Although red blood cell (RBC) transfusion is commonly used, it is associated with higher rates of postpartum complications, including pneumonia, renal failure, and cardiac events (Kloka et al.).
Patient Blood Management (PBM) is an evidence-based approach that aims to optimize a patient's own blood and reduce avoidable transfusion through three pillars: treating anemia and iron deficiency, minimizing blood loss, and avoiding unnecessary transfusion. International guidelines support PBM in obstetrics, but data on comprehensive program implementation remain limited due to barriers such as resource constraints and the need for multidisciplinary coordination.
Aims , objectives and Hypotheses Primary Aim To assess the association between PBM implementation and blood product utilisation among all obstetric deliveries at Corniche Hospital between 2018 and 2025.
Primary Objective To estimate the change over time in the mean number of blood product units transfused per delivery (combined and by product type).
Primary Hypothesis Increasing PBM maturity over time, particularly following comprehensive PBM implementation in 2022, is associated with a significant reduction in mean blood product units transfused per delivery, after adjusting for changes in case-mix.
Secondary Objectives Secondary objectives include evaluating changes in transfusion-related practice and anemia...
Conditions: Patient Blood Management, Blood Product Transfusion for All Conditions
Parties
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Mintz.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.